Leading the revolution in vaccine technology

Renowned scientists and entrepreneurs unite to create a unique platform for rapid development of highly versatile and efficient vaccines.

Covid-19 Vaccine Laboratory

About us

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.


The discovery of dendritic cells’ role in adaptative immunity system lead to a Nobel Prize in 2011.
Ten years of research later, 3 vaccines are entering clinical trial in 2021-2022. 

Press releases

October 13, 2022

Accelerating the production of more effective prophylactic or therapeutic vaccines and adapting them to emerging or rapidly mutating pathogens is a major public health challenge.

May 20, 2022

LinKinVax puts together a highly experienced team from the world of biopharmaceuticals to lead the clinical development and upscaling of its vaccine platform

Interested in our project?